Phase Space Research

Nebius Group

NBIS · Investment summary · as of 3 August 2026

Investment summary

Portfolio decision
Pending strategy review
Price · 3 August 2026
$212.69
12-month target
Not determined
Expected return
Not determined
Next decision point
Date not announced

Business type: Transition · venture-like, not yet economically observable

Investment view

At $212.69, the operating path required by the price could not be established from the evidence on file.

Declared: the market's disagreement is the revenue ramp (ARR $7-9bn YE2026 guided, consensus FY2027 ~$10bn), not the terminal margin. The margin axis was still solved per C4 and returns NO SOLUTION.

The value rests on a terminal operating margin of 20% and a 13.0% cost of capital. Move any one of them materially and the conclusion moves with it, which is why the required-versus-demonstrated test above carries more weight here than the point value.

The strongest argument against this view: GPU-fleet residual-value collapse plus merchant-price collapse at the 2030-31 contract cliff, on a levered balance sheet (debt $8.45bn, capex $20-25bn/yr).

Underwriting bridge

QuestionEvidence-based conclusion
What drives the business?Declared: the market's disagreement is the revenue ramp (ARR $7-9bn YE2026 guided, consensus FY2027 ~$10bn), not the terminal margin. The margin axis was still solved per C4 and returns NO SOLUTION.
What do we forecast?A terminal operating margin of 20%.
What does Street forecast?Not determined — no consensus estimates are joined to this record
Where do we differ?Not determined — the house and Street are not valuing the security on a comparable instrument, so no bridge can be drawn
What is it worth?Not determined — Street avg PT ~$258 (Buy, 17 analysts, S&P Global via stockanalysis.com 2026-08): divergence is multiple-only (both use ~$10bn FY2027E; Street implies ~6.6x) per the…
Why now?Date not announced — no dated event that would resolve the disagreement is on file

What must go right

  1. By Date not announced — no test date is stated for this conditionThe condition does not occur: FY2026 group revenue < $3.0bn at the FY2026 report (~Feb 2027) - below guidance floorWhere it stands: Not determined — no current reading of this metric is on file
  2. By Date not announced — no test date is stated for this conditionThe condition does not occur: YE2026 annualized run-rate revenue (ARR) < $7.0bn at the Q4'26 report - below reiterated guidance floorWhere it stands: Not determined — no current reading of this metric is on file
  3. By Date not announced — no test date is stated for this conditionThe condition does not occur: Microsoft or Meta agreement terminated, materially reduced, or disclosed as behind schedule in any quarterly report or 6-KWhere it stands: Not determined — no current reading of this metric is on file

Catalysts and falsifiers

Date not announced — no dated event that would resolve the disagreement is on file

Risk and sell discipline

Impairment case

GPU-fleet residual-value collapse plus merchant-price collapse at the 2030-31 contract cliff, on a levered balance sheet (debt $8.45bn, capex $20-25bn/yr). Tier 1 contracts truncate the left tail through 2030 (counterparties owe ~$44bn; $4.8bn prepaid; $9.3bn cash), so stated loss revised -94.9% -> -80% and p 0.27 -> 0.20 (Principle 5; judgment, flagged). Not a going-concern case inside the contract window; becomes one post-cliff if merchant pricing collapses.

Estimated probability 20%, against the 12% level at which the position would be resized. It sits above that level, so this case could not be carried at full size.

Fundamental invalidation

Falsifiable and fundamental — not one of them is a price condition.

Price-based risk trigger

A daily close below $159.52 triggers an immediate review of the thesis and pauses additional buying. It is not an automatic sell unless a separate fundamental invalidation condition has been breached.

Upside sell discipline

Trim/exit when price implies > 7.0x FY2027E EV/S (top of the neocloud band) ~= $275 at current consensus revenue and share count, or when forward E[R] net of costs turns negative on the then-current band midpoint.

Investment criteria

CriteriaStatusInvestment meaning
QualityMetIs the business worth owning under its declared economic type?
ValuationNot metIs the operating path required by today's price achievable?
LiquidityMetCan the intended position be built and exited in the right vehicle?
DownsideMetGPU-fleet residual-value collapse plus merchant-price collapse at the 2030-31 contract cliff, on a levered balance sheet (debt $8.45bn, capex $20-25bn/yr).
MomentumNot determinedDoes price action support or complicate entry timing? Not established on the evidence on file.
CatalystNot determinedIs there a dated event that resolves the disagreement? Not established on the evidence on file.
ConsensusNot determinedIs the house-versus-Street disagreement identified and quantified? Not established on the evidence on file.

Quality, valuation and liquidity can prevent a position on their own. The remaining four inform timing, sizing and monitoring, and never reject an investment by themselves.

Bottom line

The evidence does not establish a mispricing in either direction on the instrument this business can currently be valued on. The most important unresolved uncertainty is the permanent-loss mechanism: GPU-fleet residual-value collapse plus merchant-price collapse at the 2030-31 contract cliff, on a levered balance sheet (debt $8.45bn, capex $20-25bn/yr). The next evidence that should change the portfolio decision is the next scheduled results, or a daily close below $159.52, which forces an immediate review.